Obsessive-Compulsive Disorder
A mental health condition where a person has uncontrollable, recurring thoughts (obsessions) and behaviors (compulsions) they feel the urge to repeat over and over.
Emergency Management: Severe functional impairment where the patient stops eating or drinking due to contamination fears, requiring inpatient hospitalization.
Obsessive-Compulsive Disorder (OCD) is a chronic psychiatric disorder characterized by the presence of obsessions (intrusive, unwanted, distressing thoughts, images, or urges) and/or compulsions (repetitive behaviors or mental acts performed to alleviate the anxiety caused by the obsessions).
Detailed Overview
OCD severely impairs daily functioning and consumes significant time (>1 hour per day). Patients usually have insight, recognizing that their obsessions are irrational, yet they feel completely unable to resist the compulsions. Common themes include contamination, symmetry, unacceptable aggressive or sexual thoughts, and harm. The neurobiology involves dysregulation in the cortico-striato-thalamo-cortical (CSTC) circuitry. Treatment requires a combination of high-dose Serotonin Reuptake Inhibitors (SRIs) and a specific form of Cognitive Behavioral Therapy called Exposure and Response Prevention (ERP).
Epidemiology & Demographics
Lifetime prevalence is 2-3%. It affects males and females equally overall, though childhood onset is more common in males, and female onset often peaks in the early 20s or peripartum period.
Etiological Mechanism
The exact cause is multifactorial, involving genetic predisposition (high heritability in monozygotic twins), neurobiological factors (serotonin and glutamate dysfunction), and environmental triggers (stress, trauma). In children, PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) is a debated etiology where strep antibodies cross-react with basal ganglia tissue.
Primary Causes
Genetic vulnerability
CSTC circuit dysregulation
Serotonergic dysfunction
OCD is associated with hyperactivity in the cortico-striato-thalamo-cortical (CSTC) loop. Specifically, there is increased metabolic activity in the orbitofrontal cortex (OFC, involved in recognizing errors and harm), the anterior cingulate cortex (ACC, involved in emotional processing), and the head of the caudate nucleus. The normal 'brake' mechanism in the striatum fails to suppress worry signals, creating a continuous loop of error signals that the patient experiences as an obsession. Performing a compulsion temporarily reduces the anxiety, negatively reinforcing the behavior.
Diagnostic Criteria & Guidelines
DSM-5 criteria require the presence of obsessions, compulsions, or both. The obsessions or compulsions must be time-consuming (e.g., take more than 1 hour per day) or cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. The symptoms are not attributable to the physiological effects of a substance or another medical/mental condition.
The gold standard is a combination of pharmacotherapy and psychotherapy. SSRIs at high doses (e.g., Fluoxetine 40-80 mg/day, Sertraline 150-200 mg/day, Fluvoxamine 200-300 mg/day) are first-line medications; note that OCD requires higher doses than depression, and an adequate trial is 8-12 weeks. Psychotherapy must be Exposure and Response Prevention (ERP), a specific CBT where the patient is exposed to the feared stimulus and prevented from performing the compulsion.
Second-Line & Adjunctive Therapy
Clomipramine (Anafranil), a TCA with strong serotonergic properties, dosed up to 250 mg/day (monitor ECG for QTc prolongation). Augmentation with atypical antipsychotics (e.g., Aripiprazole 2-10 mg/day or Risperidone) can be used for SSRI-resistant cases.
Surgical & Procedural Management
For severe, extremely treatment-refractory cases: Deep Brain Stimulation (DBS) targeting the anterior limb of the internal capsule (ALIC) or ventral striatum. Ablative procedures (Anterior Cingulotomy or Capsulotomy) are rarely performed as a last resort.
Patient Counseling & Advice
Explain the biological nature of OCD to reduce guilt, especially for taboo intrusive thoughts (e.g., harming a child). Prepare the patient that ERP therapy will initially increase anxiety, but this anxiety will habituate over time if the compulsion is not performed. Emphasize that SSRIs may take up to 12 weeks to show full effect.
Follow-Up & Monitoring Schedule
Monthly psychiatric evaluations during medication titration, assessing Y-BOCS score and monitoring for SSRI side effects (sexual dysfunction, GI upset).
Preventive Strategies
Cannot be definitively prevented. Early recognition and initiation of ERP in childhood can prevent severe adult impairment.
Chronic, waxing and waning course. With optimal treatment (SSRI + ERP), about 50-70% of patients achieve a significant reduction in symptoms, though complete remission is rare. Left untreated, it is progressive and severely disabling.